| RS431825351 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825352 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825354 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825357 |
BRCA2
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS431825359 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825360 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825362 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825363 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825364 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825368 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825370 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825371 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825372 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825373 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825374 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825375 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825376 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825377 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825379 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825380 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825382 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825384 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825386 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825387 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS431825388 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825389 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825390 |
BRCA1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Breast-ovarian cancer |
| RS431825391 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825392 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825394 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825395 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825396 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825397 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825398 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825399 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825400 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS431825401 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825402 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825403 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825404 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825406 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS431825407 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825409 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825410 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825412 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825414 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS431825415 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825417 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431825420 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS431905486 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS431905493 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, type vi |
| RS431905494 |
ARSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, type vi |
| RS431905495 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS431905496 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS431905497 |
IFT80
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 2, Asphyxiating thoracic dystrophy 2 |
| RS431905498 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS431905499 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS431905500 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS431905501 |
PGK1
|
Health Risk |
Pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS431905502 |
PGK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, PGK1-related disorder |
| RS431905503 |
PGK1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS431905504 |
SLC6A3
|
Health Risk |
Pathogenic |
Classic dopamine transporter deficiency syndrome, Parkinsonism-dystonia |
| RS431905505 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS431905506 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS431905507 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Jeune thoracic dystrophy |
| RS431905508 |
NEK1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 6 with or without polydactyly, Short-rib thoracic dysplasia 6 with or without polydactyly |
| RS431905509 |
SLC25A1
|
Health Risk |
Pathogenic/Likely pathogenic |
D, L-2-hydroxyglutaric aciduria |
| RS431905510 |
SLC25A1
|
Health Risk |
Likely pathogenic |
D, L-2-hydroxyglutaric aciduria |
| RS431905511 |
SNCA
|
Health Risk |
Pathogenic |
Autosomal dominant Parkinson disease 1, Autosomal dominant Parkinson disease 1 |
| RS431905512 |
STX11
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis |
| RS431905513 |
TNC
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 56, Autosomal dominant nonsyndromic hearing loss 56 |
| RS431905514 |
SLC6A3
|
Health Risk |
Likely pathogenic |
Classic dopamine transporter deficiency syndrome, Parkinsonism-dystonia |
| RS431905515 |
SLC6A3
|
Health Risk |
Pathogenic |
Classic dopamine transporter deficiency syndrome, Classic dopamine transporter deficiency syndrome |
| RS431905516 |
SLC6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic dopamine transporter deficiency syndrome, Parkinsonism-dystonia |
| RS431905517 |
SLC26A5
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 61, Autosomal recessive nonsyndromic hearing loss 61 |
| RS431905518 |
SLC26A5
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 61, Autosomal recessive nonsyndromic hearing loss 61 |
| RS431905519 |
DYNC2I2
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 11 with or without polydactyly, Short-rib thoracic dysplasia 11 with or without polydactyly |
| RS431905520 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS431905521 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Jeune thoracic dystrophy |
| RS431905522 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS4369876 |
SCN9A
|
Health Risk |
Conflicting classifications of pathogenicity |
Paroxysmal extreme pain disorder, Channelopathy-associated congenital insensitivity to pain |
| RS439898 |
GBA1
|
Health Risk |
Pathogenic |
Gaucher disease, Gaucher disease |
| RS4402960 |
IGF2BP2
|
Health Risk |
risk factor |
Diabetes mellitus type 2, susceptibility to |
| RS4493011 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Cardiovascular phenotype |
| RS4494157 |
FCN3
|
Health Risk |
risk factor |
Rheumatic heart disease, Rheumatic heart disease |
| RS4508371 |
MYO1E
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 6, Focal segmental glomerulosclerosis 6 |
| RS4512367 |
PREX2
|
Health Risk |
association |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS4524 |
F5
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to activated protein C resistance, Congenital factor V deficiency |
| RS453602 |
PDLIM4
|
Health Risk |
risk factor |
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15, BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15 |
| RS4538 |
CYP11B2
|
Health Risk |
Likely pathogenic |
CYP11B2-related disorder, CYP11B2-related disorder |
| RS45437094 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS45437099 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block, type 1A |
| RS45437192 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45437193 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45437797 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45438192 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45438205 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45438400 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS45438592 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Hereditary cancer-predisposing syndrome |
| RS45441497 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |